Himisha Beltran
, Executive Director · Mass General Brigham
Credentials: · · · · ·
History
Research
Integrative clinical genomics of advanced prostate cancer
Cell · 2015 · 2,800 citations
Nature Biotechnology · 2013 · 1,863 citations
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Nature Medicine · 2016 · First of 19 authors · 1,436 citations
53 papers
46 papers
33 papers
- BR
32 papers · 1 as a resident
- MM
32 papers
Felix Feng
26 papers
- HS
26 papers
25 papers
Grants
- 2023–2028
- 2023–2028
"DNMT and TET1 Reprogramming as a Targetable Mechanism of Resistance in Advanced Prostate Cancer"
National Cancer Institute · R01
PI · $2.6M · Weill Medical Coll of Cornell Univ
- 2020–2027
Molecular Mechanisms Underlying Lineage Plasticity in Prostate Cancer
National Cancer Institute · R37
Contact PI · $4.1M · Dana-Farber Cancer Inst
- 2017–2023
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
National Cancer Institute · P50
Project lead · $1.8M · Weill Medical Coll of Cornell Univ
Clinical trials
- 2013–2017
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
- 2011–2013
Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer
Principal investigator · Terminated · Phase 2
Weill Medical College of Cornell University
- 2021–2027
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Site PI · Recruiting · Phase 2
University of British Columbia
- 2021–2029
Site PI · Recruiting · Phase 1, Phase 2
Weill Medical College of Cornell University